Clinical Trials Browser

Recruiting × NIH × Head and Neck Neoplasms × Clear all

NCT04915183 2026-05-22

Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

Phase 2 Recruiting

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Hearing Loss

NCT03429036 2026-04-29

Biospecimen Procurement for Head and Neck Disorders

Head and Neck Neoplasms, Hearing Disorders, Laryngeal Diseases, Pharyngeal Neoplasms

NCT06479811 2026-04-28

[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers

Phase 1 Recruiting

CNSEndocrineGenitourinaryHead & Neck

Head and Neck Neoplasms, Kidney Neoplasms, Paraganglioma, Pheochromocytoma

NCT06303180 2025-11-14

NIDCD Otolaryngology Clinical Protocol Biospecimen Bank

Head and Neck Neoplasms, Hearing Disorders, Laryngeal Diseases, Speech, Hearing Loss